
AstraZeneca covid-19 vaccine may hinder blood clotting in rare cases
9 June 2021
Research suggests the Oxford/AstraZeneca coronavirus vaccine is associated with a slightly increased risk of some bleeding disorders, but its benefits continue to outweigh the risks








